Zahednasab H - Search Results

1

Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis.

Balood M, Mesbah-Namin SA, Sanati MH, Zahednasab H, Sahraian MA, Ataei M. Balood M, et al. Among authors: zahednasab h. Mol Biol Rep. 2014 Feb;41(2):613-6. doi: 10.1007/s11033-013-2898-3. Epub 2013 Dec 25. Mol Biol Rep. 2014. PMID: 24368589

2

Relationship between NF-κB1 -94 ins/del ATTG polymorphism and susceptibility of multiple sclerosis in Iranian MS patients.

Zahednasab H, Mesbah-Namin SA, Sahraian MA, Balood M, Doosti R. Zahednasab H, et al. Neurosci Lett. 2013 Jun 17;545:46-9. doi: 10.1016/j.neulet.2013.04.014. Epub 2013 Apr 22. Neurosci Lett. 2013. PMID: 23618653

3

Elevated serum levels of lysophosphatidic acid in patients with multiple sclerosis.

Balood M, Zahednasab H, Siroos B, Mesbah-Namin SA, Torbati S, Harirchian MH. Balood M, et al. Among authors: zahednasab h. Hum Immunol. 2014 May;75(5):411-3. doi: 10.1016/j.humimm.2014.02.021. Epub 2014 Feb 12. Hum Immunol. 2014. PMID: 24530753

4

Secretory phospholipase A2 activity in serum and cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.

Siroos B, Balood M, Zahednasab H, Mesbah-Namin SA, Pourgholy F, Harirchian MH. Siroos B, et al. Among authors: zahednasab h. J Neuroimmunol. 2013 Sep 15;262(1-2):125-7. doi: 10.1016/j.jneuroim.2013.06.009. Epub 2013 Jul 13. J Neuroimmunol. 2013. PMID: 23859159

5

Increased autotaxin activity in multiple sclerosis.

Zahednasab H, Balood M, Harirchian MH, Mesbah-Namin SA, Rahimian N, Siroos B. Zahednasab H, et al. J Neuroimmunol. 2014 Aug 15;273(1-2):120-3. doi: 10.1016/j.jneuroim.2014.06.006. Epub 2014 Jun 19. J Neuroimmunol. 2014. PMID: 24984830

6

The role of miR-326 and miR-26a in MS disease activity.

Zahednasab H, Balood M. Zahednasab H, et al. Gene. 2014 Sep 10;548(1):158. doi: 10.1016/j.gene.2014.07.014. Epub 2014 Jul 8. Gene. 2014. PMID: 25014135 No abstract available.

7

Soluble CD40 ligand derived from serum is not correlated with early MS.

Zahednasab H, Siroos B, Balood M, Aleagha MSE, Harirchian MH. Zahednasab H, et al. Mult Scler Relat Disord. 2017 May;14:29-31. doi: 10.1016/j.msard.2016.11.004. Epub 2016 Nov 10. Mult Scler Relat Disord. 2017. PMID: 28619427

8

Comment on "matrix metalloproteinase-7 and matrix metalloproteinase-9 in pediatric multiple sclerosis".

Zahednasab H, Balood M, Mesbah-Namin SA. Zahednasab H, et al. Pediatr Neurol. 2013 Mar;48(3):255. doi: 10.1016/j.pediatrneurol.2012.12.002. Pediatr Neurol. 2013. PMID: 23419481 No abstract available.

9

Coenzyme Q10 supplementation and multiple sclerosis.

Zahednasab H, Mesbah-Namin SA, Balood M. Zahednasab H, et al. Nutr Neurosci. 2015 May;18(4):192. doi: 10.1179/1476830514Y.0000000126. Epub 2014 Apr 17. Nutr Neurosci. 2015. PMID: 24742336 No abstract available.

10

The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility.

Bahreini SA, Jabalameli MR, Saadatnia M, Zahednasab H. Bahreini SA, et al. Among authors: zahednasab h. J Neuroimmunol. 2010 Dec 15;229(1-2):5-15. doi: 10.1016/j.jneuroim.2010.08.002. Epub 2010 Sep 15. J Neuroimmunol. 2010. PMID: 20832869 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters